Which of your patients could benefit from JYSELECA?

Patients with UC in the SELECTION study had varying  levels of treatment experience

Biologic-Naïve patients in the SELECTION clinical trial (n = 659)1

Concomitant medications at baseline



Reference: 1. Feagan BG, Danese S, Loftus EV Jr, et al. Lancet 2021;397:2372–2384.